2021-11-102022-11-292022-11-29false13736366222 HEALTHCARE SERVICES LIMITED2023-11-04iso4217:GBPxbrli:pure137363662021-11-10137363662022-11-29137363662021-11-102022-11-29137363662021-11-09137363662021-11-09137363662021-11-092021-11-0913736366bus:SmallEntities2021-11-102022-11-2913736366bus:AuditExempt-NoAccountantsReport2021-11-102022-11-2913736366bus:FullAccounts2021-11-102022-11-2913736366bus:PrivateLimitedCompanyLtd2021-11-102022-11-2913736366core:WithinOneYear2022-11-2913736366core:AfterOneYear2022-11-2913736366core:WithinOneYear2021-11-0913736366core:AfterOneYear2021-11-0913736366core:ShareCapital2022-11-2913736366core:SharePremium2022-11-2913736366core:RevaluationReserve2022-11-2913736366core:OtherReservesSubtotal2022-11-2913736366core:RetainedEarningsAccumulatedLosses2022-11-2913736366core:ShareCapital2021-11-0913736366core:SharePremium2021-11-0913736366core:RevaluationReserve2021-11-0913736366core:OtherReservesSubtotal2021-11-0913736366core:RetainedEarningsAccumulatedLosses2021-11-0913736366core:LandBuildings2022-11-2913736366core:PlantMachinery2022-11-2913736366core:Vehicles2022-11-2913736366core:FurnitureFittings2022-11-2913736366core:OfficeEquipment2022-11-2913736366core:NetGoodwill2022-11-2913736366core:IntangibleAssetsOtherThanGoodwill2022-11-2913736366core:ListedExchangeTraded2022-11-2913736366core:UnlistedNon-exchangeTraded2022-11-2913736366core:LandBuildings2021-11-0913736366core:PlantMachinery2021-11-0913736366core:Vehicles2021-11-0913736366core:FurnitureFittings2021-11-0913736366core:OfficeEquipment2021-11-0913736366core:NetGoodwill2021-11-0913736366core:IntangibleAssetsOtherThanGoodwill2021-11-0913736366core:ListedExchangeTraded2021-11-0913736366core:UnlistedNon-exchangeTraded2021-11-0913736366core:LandBuildings2021-11-102022-11-2913736366core:PlantMachinery2021-11-102022-11-2913736366core:Vehicles2021-11-102022-11-2913736366core:FurnitureFittings2021-11-102022-11-2913736366core:OfficeEquipment2021-11-102022-11-2913736366core:NetGoodwill2021-11-102022-11-2913736366core:IntangibleAssetsOtherThanGoodwill2021-11-102022-11-2913736366core:ListedExchangeTraded2021-11-102022-11-2913736366core:UnlistedNon-exchangeTraded2021-11-102022-11-2913736366core:MoreThanFiveYears2021-11-102022-11-2913736366core:Non-currentFinancialInstruments2022-11-2913736366core:Non-currentFinancialInstruments2021-11-0913736366dpl:CostSales2021-11-102022-11-2913736366dpl:DistributionCosts2021-11-102022-11-2913736366core:LandBuildings2021-11-102022-11-2913736366core:PlantMachinery2021-11-102022-11-2913736366core:Vehicles2021-11-102022-11-2913736366core:FurnitureFittings2021-11-102022-11-2913736366core:OfficeEquipment2021-11-102022-11-2913736366dpl:AdministrativeExpenses2021-11-102022-11-2913736366core:NetGoodwill2021-11-102022-11-2913736366core:IntangibleAssetsOtherThanGoodwill2021-11-102022-11-2913736366dpl:GroupUndertakings2021-11-102022-11-2913736366dpl:ParticipatingInterests2021-11-102022-11-2913736366dpl:GroupUndertakingscore:ListedExchangeTraded2021-11-102022-11-2913736366core:ListedExchangeTraded2021-11-102022-11-2913736366dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-11-102022-11-2913736366core:UnlistedNon-exchangeTraded2021-11-102022-11-2913736366dpl:CostSales2021-11-092021-11-0913736366dpl:DistributionCosts2021-11-092021-11-0913736366core:LandBuildings2021-11-092021-11-0913736366core:PlantMachinery2021-11-092021-11-0913736366core:Vehicles2021-11-092021-11-0913736366core:FurnitureFittings2021-11-092021-11-0913736366core:OfficeEquipment2021-11-092021-11-0913736366dpl:AdministrativeExpenses2021-11-092021-11-0913736366core:NetGoodwill2021-11-092021-11-0913736366core:IntangibleAssetsOtherThanGoodwill2021-11-092021-11-0913736366dpl:GroupUndertakings2021-11-092021-11-0913736366dpl:ParticipatingInterests2021-11-092021-11-0913736366dpl:GroupUndertakingscore:ListedExchangeTraded2021-11-092021-11-0913736366core:ListedExchangeTraded2021-11-092021-11-0913736366dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-11-092021-11-0913736366core:UnlistedNon-exchangeTraded2021-11-092021-11-0913736366core:NetGoodwill2022-11-2913736366core:IntangibleAssetsOtherThanGoodwill2022-11-2913736366core:LandBuildings2022-11-2913736366core:PlantMachinery2022-11-2913736366core:Vehicles2022-11-2913736366core:FurnitureFittings2022-11-2913736366core:OfficeEquipment2022-11-2913736366core:AfterOneYear2022-11-2913736366core:WithinOneYear2022-11-2913736366core:ListedExchangeTraded2022-11-2913736366core:UnlistedNon-exchangeTraded2022-11-2913736366core:ShareCapital2022-11-2913736366core:SharePremium2022-11-2913736366core:RevaluationReserve2022-11-2913736366core:OtherReservesSubtotal2022-11-2913736366core:RetainedEarningsAccumulatedLosses2022-11-2913736366core:NetGoodwill2021-11-0913736366core:IntangibleAssetsOtherThanGoodwill2021-11-0913736366core:LandBuildings2021-11-0913736366core:PlantMachinery2021-11-0913736366core:Vehicles2021-11-0913736366core:FurnitureFittings2021-11-0913736366core:OfficeEquipment2021-11-0913736366core:AfterOneYear2021-11-0913736366core:WithinOneYear2021-11-0913736366core:ListedExchangeTraded2021-11-0913736366core:UnlistedNon-exchangeTraded2021-11-0913736366core:ShareCapital2021-11-0913736366core:SharePremium2021-11-0913736366core:RevaluationReserve2021-11-0913736366core:OtherReservesSubtotal2021-11-0913736366core:RetainedEarningsAccumulatedLosses2021-11-0913736366core:NetGoodwill2021-11-0913736366core:IntangibleAssetsOtherThanGoodwill2021-11-0913736366core:LandBuildings2021-11-0913736366core:PlantMachinery2021-11-0913736366core:Vehicles2021-11-0913736366core:FurnitureFittings2021-11-0913736366core:OfficeEquipment2021-11-0913736366core:AfterOneYear2021-11-0913736366core:WithinOneYear2021-11-0913736366core:ListedExchangeTraded2021-11-0913736366core:UnlistedNon-exchangeTraded2021-11-0913736366core:ShareCapital2021-11-0913736366core:SharePremium2021-11-0913736366core:RevaluationReserve2021-11-0913736366core:OtherReservesSubtotal2021-11-0913736366core:RetainedEarningsAccumulatedLosses2021-11-0913736366core:AfterOneYear2021-11-102022-11-2913736366core:WithinOneYear2021-11-102022-11-2913736366core:Non-currentFinancialInstrumentscore:CostValuation2021-11-102022-11-2913736366core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-11-102022-11-2913736366core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-11-102022-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-11-102022-11-2913736366core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-11-102022-11-2913736366core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-11-102022-11-2913736366core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-11-102022-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-11-102022-11-2913736366core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-11-102022-11-2913736366core:Non-currentFinancialInstrumentscore:CostValuation2022-11-2913736366core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:CostValuation2021-11-0913736366core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-11-0913736366core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-11-0913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-11-0913736366core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-11-0913736366core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-11-0913736366core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-11-0913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-11-0913736366core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-11-0913736366bus:Director12021-11-102022-11-29

222 HEALTHCARE SERVICES LIMITED

Registered Number
13736366
(England and Wales)

Unaudited Financial Statements for the Period ended
29 November 2022

222 HEALTHCARE SERVICES LIMITED
Company Information
for the period from 10 November 2021 to 29 November 2022

Director

LARGE, Oliver Drury Helliwell, Dr

Registered Address

2nd Floor Grove House
55 Lowlands Road
Harrow
HA1 3AW

Registered Number

13736366 (England and Wales)
222 HEALTHCARE SERVICES LIMITED
Balance Sheet as at
29 November 2022

Notes

2022

£

£

Fixed assets
Intangible assets6154
Tangible assets72,343
2,497
Current assets
Stocks9450
Debtors2,330
Cash at bank and on hand3,691
6,471
Creditors amounts falling due within one year11(15,490)
Net current assets (liabilities)(9,019)
Total assets less current liabilities(6,522)
Provisions for liabilities12(445)
Net assets(6,967)
Capital and reserves
Called up share capital100
Profit and loss account(7,067)
Shareholders' funds(6,967)
The financial statements were approved and authorised for issue by the Director on 4 November 2023, and are signed on its behalf by:
LARGE, Oliver Drury Helliwell, Dr
Director
Registered Company No. 13736366
222 HEALTHCARE SERVICES LIMITED
Notes to the Financial Statements
for the period ended 29 November 2022

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Principal activities
The principal activity of the company in the year under review was that of providing general medical activities.
4.Accounting policies
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Office Equipment25
Intangible assets policy
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Stocks policy
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Taxation policy
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax policy
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
5.Employee information

2022
Average number of employees during the year2
6.Intangible assets

Other

Total

££
Cost or valuation
Additions170170
At 29 November 22170170
Amortisation and impairment
Charge for year1616
At 29 November 221616
Net book value
At 29 November 22154154
At 09 November 21--
7.Property, plant and equipment

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
Additions852,6452,730
At 29 November 22852,6452,730
Depreciation and impairment
Charge for year8379387
At 29 November 228379387
Net book value
At 29 November 22772,2662,343
At 09 November 21---
8.Guarantees and their terms, directors
The director's current account balance of £463 relates to the director.
9.Stocks

2022

£
Raw materials and consumables450
Total450
10.Debtors within one year

2022

£
Trade debtors / trade receivables214
Other debtors309
Prepayments and accrued income1,807
Total2,330
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
11.Creditors within one year

2022

£
Trade creditors / trade payables1,110
Other creditors10,663
Accrued liabilities and deferred income3,717
Total15,490
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
12.Provisions for liabilities

2022

£
Net deferred tax liability (asset)445
Total445